Journal Information
Vol. 99. Issue 1.
Pages 118-120 (1 January 2024)
Visits
3686
Vol. 99. Issue 1.
Pages 118-120 (1 January 2024)
Letter - Clinical
Full text access
Acquired lymphangiectasia of the lip in a patient with Crohn’s disease
Visits
3686
Ana Llull-Ramos
Corresponding author
anallullramos@gmail.com

Corresponding author.
, Juan Garcías-Ladaria, Inés Gracia-Darder, Aniza Giacaman
Department of Dermatology, Son Espases University Hospital, Palma de Mallorca, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (1)
Table 1. Summary of cases of acquired lymphangiectasia of the lip associated with Crohn's disease.
Full Text
Dear Editor,

Acquired lymphangiectasia is a rare complication of lymphatic obstruction. It has been described in association with malignancy and granulomatous diseases, namely orofacial granulomatosis, Crohn’s Disease (CD), and tuberculosis. It must be distinguished from a congenital malformation, generally referred to as lymphangioma.1 Herein we describe a case of acquired lymphangiectasia of the lip in a girl with CD, to our knowledge the first case of this association in pediatric age.

An 11-year-old girl was referred to our Dermatology Department due to persistent cheilitis and gingivitis since she was 4 years old. A therapeutic attempt with gingivoplasty had been performed at the age of 8 without success. No histology was available from the intervention. Later, at the age of 9, she had been diagnosed with Crohn’s disease after intestinal biopsy and was treated with azathioprine and infliximab. However, the cheilitis persisted.

Physical examination showed crusty lesions and flaccid blisters on both lips, as well as erythema with fissures on the gums and jugal mucosa (Fig. 1 A and B). A biopsy of the labial mucosa was performed.

Figure 1.

Clinical appearance of the girl’s lips (A and B).

(0.28MB).

Histology showed epidermal hyperplasia without atypia with lichenoid pattern inflammation and lymphangiectasia (Fig. 2A). The presence of numerous podoplanin-positive subepithelial dilated vessels with a lymphatic appearance is noteworthy (Fig. 2B). Further investigations, including patch testing with the European standard and cosmetics series, and a facial MRI were normal. Topical corticosteroid treatment was prescribed with the intention of reducing the associated inflammation, followed by topical rapamycin 0.2% to decrease the lymphatic component, with no clear improvement after two months.

Figure 2.

(A) Labial mucosa fragment lined by squamous epithelium with marked acanthosis, spongiosis, hyperkeratosis and no keratinocyte atypia, with a dense lymphoplasmacytic infiltrate in the deeper areas without granulomas, with focal lichenoid change (Hematoxylin & eosin, ×100). (B) Positive immunostaining for podoplanin in subepithelial lymphatic vessels (Hematoxylin & eosin, ×100).

(0.88MB).

Granulomatous cheilitis presents as orofacial inflammation secondary to non-necrotizing granulomas. It can present isolated or in the context of granulomatous systemic disease. In children, granulomatous cheilitis is more often associated with CD than in adults, being the first manifestation in 5%‒10% of cases of inflammatory bowel disease.2,3

Acquired lymphangiectasia in CD is thought to develop as a consequence of chronic granulomatous inflammation. It is described most often in the genital area. In a literature review, we found four cases of acquired orofacial lymphangiectasia associated with CD (Table 1).1,2,4 As in the case presented here, in two of these patients no granulomas were observed on histology, and in another case, they were only observed in the second biopsy. The medical treatment could have reduced the inflammation, leaving only the residual lymphangiectasia.1,2,4

Table 1.

Summary of cases of acquired lymphangiectasia of the lip associated with Crohn's disease.

N (Ref)  Year  Age/Sex  LIP histological findings  Treatment  Of outcome 
11  2017  18/F  Widely dilated superficial lymphatic channels  Azathioprine, mesalazine, infliximab, 0.03% topical tacrolimus and lip cryotherapy  Good cosmetic result 
21  2017  33/M  Superficial dilated lymphatics and patchy inflammation  Triamcinolone injections, 1% topical hydrocortisone cream, oral mesalazine  No treatment needed 
32202029/F1st biopsy: superficial dilated vessels and dense inflammatory infiltrate with a tiny granuloma  InfliximabImprovement
2nd biopsy: superficial lymphangiectasia, inflammatory infiltrate and small granuloma 
44202130/F1st biopsy: proliferation of ectatic lymphatic channels  Methotrexate and infliximabImprovement
2nd biopsy: granulomata adjacent to dilated lymphatic channels 
5 (present case)  2021  11/F  Lichenoid pattern inflammation and lymphangiectasia  Azathioprine, infliximab, topical corticosteroids and 0.2% topical rapamycin  No clear improvement 

In the absence of granulomatous inflammation, lymphangiectasia can be treated with cryotherapy, sclerotherapy, surgical excision, laser ablation, or photocoagulation.1 In our case, topical rapamycin was attempted with no results at 2 months. No cases of acquired lymphangiectasia have been successfully treated with topical rapamycin, but 0.1% topical sirolimus has been effective in cutaneous microcystic lymphatic malformations in children and adults.5

In conclusion, the presence of orofacial acquired lymphangiectasia could be an early marker of inflammatory bowel disease even in the absence of granulomatous cheilitis or digestive symptoms. Its diagnosis could help in the early detection of CD.

Financial support

None declared.

Authors' contributions

Ana Llull-Ramos: Concepcion; design; acquisition of data; drafting the article; analysis of data; final approval of the version to be published.

Juan Garcías-Ladaria: Acquisition of data; analysis of data; final approval of the version to be published.

Inés Gracia-Darder: Acquisition of data; analysis of data; final approval of the version to be published.

Aniza Giacaman: Acquisition of data; analysis of data; final approval of the version to be published.

Conflicts of interest

None declared.

References
[1]
S. Galvin, S.R. Flint, M.E. Toner, C.M. Healy, K. Ekanayake.
Oral lymphangiectasias and Crohn’s disease: two case reports.
Oral Surg Oral Med Oral Pathol Oral Radiol, 126 (2018), pp. 31-34
[2]
V. Lenskaya, P. Panji, E.H. de Moll, K. Christian, R.G. Phelps.
Oral lymphangiectasia and gastrointestinal Crohn disease.
J Cutan Pathol, 47 (2020), pp. 1080-1084
[3]
M.W. Lam, D. Veitch, A. Barbieri, P.N. Woo.
Orofacial granulomatosis presenting with the unusual sign of lymphangiectasia successfully treated with isotretinoin.
Int J Dermatol, 59 (2020), pp. 109-110
[4]
D. Kuraitis, L. Williams, A. Murina.
Lip swelling with lymphangiectasia.
JAAD Case Rep, 11 (2021), pp. 93-95
[5]
S. Leducq, A. Caille, S. Barbarot, N. Bénéton, D. Bessis, O. Boccara, et al.
Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
Trials, 20 (2019), pp. 739

Study conducted at the Department of Dermatology, Son Espases University Hospital, Palma de Mallorca, Spain.

Download PDF
Idiomas
Anais Brasileiros de Dermatologia
Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.